Commentary on: A randomized controlled trial of fusion surgery for lumbar spinal stenosis (Forsth P, Ólafsson G, Carlsson T, Frost A, Borgström F, Fritzell P,et al. N Eng J Med 2016;374:1414-23)

Abstract

This article by Forsth et al. published in the New England Journal of Medicine entitled A randomized controlled trial of fusion surgery for lumbar spinal stenosis determined that decompressions alone vs. decompressions/fusions were equally effective in treating 1-2 level spinal stensois with/without degenerative spondylolisthesis (DS). Additionally, decompression alone reduced the perioperative morbidity, while reducuing the length of hospital stay (LOS), operative time, and surgical costs. Utilizing a randomized controlled design, the efficacy of 1-2 level decompressions alone vs. decompressions with fusions for lumbar spinal stenosis with/without DS (135 patients) was assessed in 247 patients between the ages of 50-80. Outcomes were analyzed at 2 and 5 postoperative years utilizing the 6-minute walk test, and the Oswestry disability index (ODI). At 2 and 5 postoperative years, there were no significant clinical differences between the two groups (e.g., on the average ODI or 6-minute walk test). In addition, with decompressions alone, the LOS (averaging 7.4 days for fusion vs. 4.1 days for decompression alone), surgical time, and operative costs were markedly reduced. Furthermore, at 6.5 postoperative years, reoperation rates were comparable for both groups; 22% for decompression/fusion vs. 21% for decompression alone. The authors concluded that at 2 and 5 postoperative years, patients with 1-2 level spinal stenosis did equally well with decompressions alone vs. decompressions with fusions with/without degenerative spondylolisthesis. This article offers a clear message for spinal surgeons; for older patients with 1-2 level spinal stenosis with/without DS, decompresions alone will typically suffice. This reduces patient morbidity along with LOS, operative time, and surgical costs.